Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p9
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 9/30)
Character Range: 27265–30391

20 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C8774 C8775           P8774 P8775           30   1     30
Esomeprazole  Tablet (enteric coated) 20 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C8776 C8780 C8827     P8776 P8780 P8827     30   5     30
Esomeprazole  Tablet (enteric coated) 20 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP     C11310                P11310                60   5     30
Esomeprazole  Tablet (enteric coated) 20 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C15530 C15658 C15682  P15530 P15658 P15682  60   5     30
Esomeprazole  Tablet (enteric coated) 20 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP     C15856                P15856                120  5     30

(b) omit from the column headed "Form" (all instances): Tablet (enteric coated) 20 mg (as magnesium trihydrate)
          substitute (all instances): Tablet (enteric coated) 20 mg (as magnesium)
[51] Schedule 1, Part 1, entries for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate)
(a) omit:
Esomeprazole  Tablet (enteric coated) 40 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C8902          P8902          30   1     30
Esomeprazole  Tablet (enteric coated) 40 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C8777 C8778    P8777 P8778    30   5     30
Esomeprazole  Tablet (enteric coated) 40 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP     C11370         P11370         60   5     30
Esomeprazole  Tablet (enteric coated) 40 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP NP  C15655 C15704  P15655 P15704  60   5     30
Esomeprazole  Tablet (enteric coated) 40 mg (as magnesium trihydrate)  Oral  Esomeprazole Mylan  AL  MP     C15936         P15936         120  5     30

(b) omit from the column headed "Form" (all instances): Tablet (enteric coated) 40 mg (as magnesium trihydrate)
 substitute (all instances): Tablet (enteric coated) 40 mg (as magnesium)
[52] Schedule 1, Part 1, entry for Famciclovir in the form Tablet 500 mg [Brand: Ezovir]
omit from the column headed "Responsible Person": AF substitute: XT
[53] Schedule 1, Part 1, entries for Fingolimod in the form Capsule 500 micrograms (as hydrochloride)
omit:
Fingolimod  Capsule 500 micrograms (as hydrochloride)  Oral  FINGOLIS  LR  MP  C10162 C10172     28  5     28

[54] Schedule 1, Part 1, entries for Fluoxetine in the form Capsule 20 mg (as hydrochloride)
omit:
Fluoxetine  Capsule 20 mg (as hydrochloride)  Oral  NOUMED FLUOXETINE  VO  MP NP  C4755 C6277    P4755 P6277    28  5     28
Fluoxetine  Capsule 20 mg (as hydrochloride)  Oral  NOUMED FLUOXETINE  VO  MP NP  C15582 C15666  P15582 P15666  56  2     28
Fluoxetine  Capsule 20 mg (as hydrochloride)  Oral  Prozac 20          LY  MP NP  C4755 C6277    P4755 P6277    28  5     28
Fluoxetine  Capsule 20 mg (as hydrochloride)  Oral  Prozac 20          LY  MP NP  C15582 C15666  P15582 P15666  56  2     28

[55] Schedule 1, Part 1, entries for Hypromellose in the form Eye drops 3 mg per mL, 10